FDA approves first inhaled insulin for kids with diabetes

Children with diabetes now have a needle-free insulin option as the FDA approves Afrezza, the first fast-acting inhaled ...

First FDA-approved inhaled insulin for kids could reduce daily injections

The FDA has approved the first fast-acting inhaled insulin for children with Type 1 diabetes, offering an alternative to ...
Drug Delivery Business

MannKind wins FDA approval for inhaled insulin for children with type 1, type 2 diabetes

MannKind (Nasdaq:MNKD) announced today that it received FDA approval for its Afrezza inhaled insulin powder for children.
Clinical Advisor

Afrezza Inhaled Insulin Gains FDA Approval for Pediatric Patients

Backed by phase 3 INHALE-1 data, the expanded indication provides a noninvasive, needle-free mealtime insulin alternative for children and adolescents.

US FDA approves MannKind's inhaled insulin for children

By Sahil Pandey and Sriparna Roy May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of ...
The American Journal of Managed Care

FDA Approves Inhaled Insulin for Children, Adolescents With Diabetes

Label expansion enables a rapid-acting inhaled mealtime insulin option for pediatric patients ≥6 years, addressing injection burden amid persistent unmet needs in youth diabetes management.

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks ...

FDA approves first needle-free inhaled insulin for kids with diabetes

The FDA has approved Afrezza, a fast-acting inhaled insulin, for children with diabetes. A teen who tested it for four years ...